Metformin Hydrochloride Prolonged – release and Glimepiride Tablets IP
Indication: For the management of patients with type 2 diabetes mellitus when diet, exercise and single agent (glimepiride or metformin alone) do not result in adequate glycemic control. In principle, the dosage of Amaryl M is governed by the desired blood glucose level.
PACKING: 10 X 10
% GAIN: 604.23
Similar Product: GLYCOMET GP2